CDKN3 Antibodies

Santa Cruz Biotechnology features a diverse variety of CDKN3 monoclonal antibodies for research in cell cycle regulation and tumor biology. CDKN3 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CDKN3, also known as cyclin-dependent kinase inhibitor 3, plays a crucial role in regulating the cell cycle by inhibiting cyclin-dependent kinases, thereby preventing uncontrolled cell proliferation. Its function is vital in maintaining cellular homeostasis and has implications in cancer research, as dysregulation of CDKN3 can lead to tumorigenesis. Understanding the role of CDKN3 in various cellular processes can provide insights into potential therapeutic targets for cancer treatment. CDKN3 monoclonal antibodies enable detailed investigation of cell cycle checkpoints and their regulation in normal and pathological conditions. Researchers studying CDKN3 can utilize specific conjugates including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) for enhanced detection flexibility. Santa Cruz Biotechnology monoclonal antibodies support cutting-edge research that advances our understanding of cell cycle regulation and cancer biology.